⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL839559 | 0.81 | — | — | |
| SCHEMBL161037 | 0.79 | CYP2C9 (0.35) | — | |
| SCHEMBL6835334 | 0.79 | TSHR (0.39) | — | |
| SCHEMBL16370685 | 0.79 | — | — | |
| SCHEMBL30656499 | 0.78 | ALDH1A1 (0.35) | — | |
| SCHEMBL979250 | 0.76 | GGT1 (0.38) | — | |
| SCHEMBL979248 | 0.76 | GGT1 (0.38) | — | |
| SCHEMBL8349586 | 0.76 | ALDH1A1 (0.33) | — | |
| SCHEMBL16837644 | 0.72 | ALDH1A1 (0.32) | — | |
| SCHEMBL26915243 | 0.72 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528804-B2 | Lactivicin compounds, their preparation and use as antibacterial agents | FEDORA PHARMACEUTICALS INC. (CA) | 2026-01-20 | — | — | US | disclosed |
| US-20230374005-A1 | LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS | FEDORA PHARMACEUTICALS INC. (CA) | 2023-11-23 | — | — | US | disclosed |